Recently FundedUSD 100.0KHospitals and Health Care

Brite Trace Secures $100K

Brite Trace

Company Logo

Get the full Brite Trace company profile

Access contacts, investors, buying signals & more

Start Free Trial

Brite Trace has secured $100,000 in investment capital from investors, marking a significant milestone for the company dedicated to supporting caregivers.

At Brite Trace, the primary commitment is to individuals navigating the complexities of early-stage Alzheimer's and Dementia.

The company deeply recognizes that every caregiving journey is distinct, often accompanied by feelings of stress and isolation.

Brite Trace's core mission is to enhance these situations and elevate the level of care provided to those facing these challenging conditions.

This funding round underscores investor confidence in Brite Trace's focused approach to a critical area of healthcare support.

The newly acquired capital will be strategically deployed to accelerate Brite Trace's development initiatives and expand its operational capabilities.

While specific detailed plans for the funds were not disclosed, the company plans to use the investment to further its mission of improving the caregiving experience.

This funding is expected to enable Brite Trace to enhance its existing offerings, potentially through technology advancements or expanded support programs, and broaden its reach within the caregiving community.

The investment reflects a belief in Brite Trace's potential to make a tangible difference in the lives of those it serves by addressing their unique needs.

This financial injection positions Brite Trace for continued growth and innovation within the specialized caregiving support sector.

The company is focused on leveraging this capital to strengthen its commitment to caregivers, ensuring they receive the necessary resources and support to provide high-quality care.

Brite Trace looks forward to expanding its impact, striving to alleviate the stress and isolation often associated with caregiving for early-stage Alzheimer's and Dementia patients, and fostering a more supportive and connected environment for all involved in these vital journeys.

No buying signals identified yet.

Unlock GTM Signals

Discover Brite Trace's tech stack and active buying intent signals.

View GTM Signals

Trusted by 200+ sales professionals

Unlock Investor Data

See who invested in Brite Trace and connect with key investment contacts.

Unlock Investors

Trusted by 200+ sales professionals

Unlock Key Decision-Makers

Get direct access to the key decision-makers at Brite Trace.

Unlock Decision-Makers

Trusted by 200+ sales professionals